BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 31590954)

  • 41. Outcomes of pleurectomy decortication in patients with biphasic mesothelioma.
    Lapidot M; Mazzola E; Bueno R
    J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1340-1348.e3. PubMed ID: 35513907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.
    Bölükbas S; Eberlein M; Kudelin N; Demes M; Stallmann S; Fisseler-Eckhoff A; Schirren J
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):119-23. PubMed ID: 23242984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph node involvement and metastatic lymph node ratio influence the survival of malignant pleural mesothelioma: a French multicenter retrospective study.
    Hysi I; Le Pimpec-Barthes F; Alifano M; Venissac N; Mouroux J; Regnard JF; Riquet M; Porte H
    Oncol Rep; 2014 Jan; 31(1):415-21. PubMed ID: 24142233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma.
    Otoshi T; Kataoka Y; Kaku S; Iki R; Hirabayashi M
    In Vivo; 2018; 32(2):445-450. PubMed ID: 29475935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.
    Van Gerwen M; Alpert N; Wolf A; Ohri N; Lewis E; Rosenzweig KE; Flores R; Taioli E
    Carcinogenesis; 2019 Jun; 40(4):529-536. PubMed ID: 30649229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pleural mesothelioma: is the surgeon still there?
    Opitz I; Weder W
    Ann Oncol; 2018 Aug; 29(8):1710-1717. PubMed ID: 29905765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.
    Combaz-Lair C; Galateau-Sallé F; McLeer-Florin A; Le Stang N; David-Boudet L; Duruisseaux M; Ferretti GR; Brambilla E; Lebecque S; Lantuejoul S
    Hum Pathol; 2016 Jun; 52():9-18. PubMed ID: 26980049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
    Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
    Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
    Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
    Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma.
    de Perrot M; Dong Z; Bradbury P; Patsios D; Keshavjee S; Leighl NB; Hope A; Feld R; Cho J
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimodal management of malignant pleural mesothelioma: where are we today?
    Van Schil PE; Opitz I; Weder W; De Laet C; Domen A; Lauwers P; Hendriks JM; Van Meerbeeck JP
    Eur Respir J; 2014 Sep; 44(3):754-64. PubMed ID: 24525443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma.
    Nakas A; Waller D; Lau K; Richards C; Muller S
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):72-6; discussion 76. PubMed ID: 22290929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.
    Elkiran ET; Kaplan MA; Sevinc A; Aksoy S; Demirci U; Seker M; Harputluoglu H; Ozdemir NY; Isik F; Ulas A; Inanc M; Arslan UY; Dogu GG; Isikdogan A; Buyukberber S;
    Med Oncol; 2012 Dec; 29(5):3147-54. PubMed ID: 22722923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation.
    Hasan B; Greillier L; Pallis A; Menis J; Gaafar R; Sylvester R; Fennell DA; Baas P; Surmont V; Van Meerbeeck JP; O'brien ME
    Eur J Cancer; 2014 Nov; 50(16):2771-82. PubMed ID: 25155251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
    Cao C; Tian D; Park J; Allan J; Pataky KA; Yan TD
    Lung Cancer; 2014 Feb; 83(2):240-5. PubMed ID: 24360321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma.
    Mairinger FD; Walter RF; Ting S; Vollbrecht C; Kollmeier J; Griff S; Hager T; Mairinger T; Christoph DC; Theegarten D; Schmid KW; Wohlschlaeger J
    Future Oncol; 2014 May; 10(6):995-1005. PubMed ID: 24941985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of postoperative radiotherapy in the management of malignant pleural mesothelioma : A propensity score matching of the SEER database.
    Abdel-Rahman O
    Strahlenther Onkol; 2017 Apr; 193(4):276-284. PubMed ID: 28044200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?
    Kim S; Bull DA; Garland L; Khalpey Z; Stea B; Yi S; Hsu CC
    Ann Thorac Surg; 2019 Jan; 107(1):194-201. PubMed ID: 30278171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
    Cedrés S; Ponce-Aix S; Zugazagoitia J; Sansano I; Enguita A; Navarro-Mendivil A; Martinez-Marti A; Martinez P; Felip E
    PLoS One; 2015; 10(3):e0121071. PubMed ID: 25774992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.